JP2018077253A5 - - Google Patents

Download PDF

Info

Publication number
JP2018077253A5
JP2018077253A5 JP2018004851A JP2018004851A JP2018077253A5 JP 2018077253 A5 JP2018077253 A5 JP 2018077253A5 JP 2018004851 A JP2018004851 A JP 2018004851A JP 2018004851 A JP2018004851 A JP 2018004851A JP 2018077253 A5 JP2018077253 A5 JP 2018077253A5
Authority
JP
Japan
Prior art keywords
mass spectrometry
liquid chromatography
amount
ionization
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018004851A
Other languages
English (en)
Japanese (ja)
Other versions
JP6821610B2 (ja
JP2018077253A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018077253A publication Critical patent/JP2018077253A/ja
Publication of JP2018077253A5 publication Critical patent/JP2018077253A5/ja
Application granted granted Critical
Publication of JP6821610B2 publication Critical patent/JP6821610B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018004851A 2014-05-12 2018-01-16 質量分析によるタモキシフェンおよびその代謝産物の定量化 Active JP6821610B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461992214P 2014-05-12 2014-05-12
US61/992,214 2014-05-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016567654A Division JP6279104B2 (ja) 2014-05-12 2015-05-12 質量分析によるタモキシフェンおよびその代謝産物の定量化

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021000689A Division JP2021073450A (ja) 2014-05-12 2021-01-06 質量分析によるタモキシフェンおよびその代謝産物の定量化

Publications (3)

Publication Number Publication Date
JP2018077253A JP2018077253A (ja) 2018-05-17
JP2018077253A5 true JP2018077253A5 (enExample) 2018-06-28
JP6821610B2 JP6821610B2 (ja) 2021-01-27

Family

ID=54367635

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2016567654A Active JP6279104B2 (ja) 2014-05-12 2015-05-12 質量分析によるタモキシフェンおよびその代謝産物の定量化
JP2018004851A Active JP6821610B2 (ja) 2014-05-12 2018-01-16 質量分析によるタモキシフェンおよびその代謝産物の定量化
JP2021000689A Pending JP2021073450A (ja) 2014-05-12 2021-01-06 質量分析によるタモキシフェンおよびその代謝産物の定量化
JP2023080724A Pending JP2023109874A (ja) 2014-05-12 2023-05-16 質量分析によるタモキシフェンおよびその代謝産物の定量化
JP2025018885A Pending JP2025081382A (ja) 2014-05-12 2025-02-07 質量分析によるタモキシフェンおよびその代謝産物の定量化

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016567654A Active JP6279104B2 (ja) 2014-05-12 2015-05-12 質量分析によるタモキシフェンおよびその代謝産物の定量化

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021000689A Pending JP2021073450A (ja) 2014-05-12 2021-01-06 質量分析によるタモキシフェンおよびその代謝産物の定量化
JP2023080724A Pending JP2023109874A (ja) 2014-05-12 2023-05-16 質量分析によるタモキシフェンおよびその代謝産物の定量化
JP2025018885A Pending JP2025081382A (ja) 2014-05-12 2025-02-07 質量分析によるタモキシフェンおよびその代謝産物の定量化

Country Status (9)

Country Link
US (6) US9459267B2 (enExample)
EP (2) EP3143392B1 (enExample)
JP (5) JP6279104B2 (enExample)
CN (2) CN110044998B (enExample)
AU (6) AU2015259294A1 (enExample)
BR (1) BR112016026459B1 (enExample)
CA (1) CA2948823C (enExample)
SA (1) SA516380291B1 (enExample)
WO (1) WO2015175561A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2384437B1 (en) * 2008-12-24 2018-12-12 Quest Diagnostics Investments Incorporated Mass spectrometry assay for pregnenolone and 17-hydroxypregnenolone
AU2015259294A1 (en) 2014-05-12 2016-12-01 Quest Diagnostics Investments Llc Quantitation of tamoxifen and metabolites thereof by mass spectrometry
CN105159539B (zh) * 2015-09-10 2018-06-01 京东方科技集团股份有限公司 可穿戴设备的触控响应方法、装置及可穿戴设备
CA3153535A1 (en) 2019-10-10 2021-04-15 Rachel MULLEN Liquid chromatography-mass spectrometry (lc-ms) methods for analyzing ampholyte lot variation
JP2023512075A (ja) 2020-01-31 2023-03-23 リジェネロン・ファーマシューティカルズ・インコーポレイテッド オリゴヌクレオチドを特徴解析するための液体クロマトグラフィーおよび質量分析の使用
US12105102B2 (en) 2022-03-30 2024-10-01 University Of Utah Research Foundation Methods for quantifying insulin-like growth factor-1 and insulin-like growth factor-2

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5119827A (en) * 1990-09-05 1992-06-09 Board Of Regents, The University Of Texas System Mechanisms of antiestrogen resistance in breast cancer
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
EP0700521B1 (en) 1993-05-28 2003-06-04 Baylor College Of Medicine Method and mass spectrometer for desorption and ionization of analytes
IES950928A2 (en) * 1995-12-08 1996-02-21 Bunskellig Limited "A process for analysing a fluid"
GB9717926D0 (en) 1997-08-22 1997-10-29 Micromass Ltd Methods and apparatus for tandem mass spectrometry
AU2463299A (en) 1998-01-23 1999-08-09 Analytica Of Branford, Inc. Mass spectrometry from surfaces
CN1871517A (zh) * 2002-02-19 2006-11-29 免疫公司 快速有效分离循环癌细胞的方法和试剂
US7485623B2 (en) * 2002-12-18 2009-02-03 Laboratoires Besins International Sa Reduction of breast density with 4-hydroxy tamoxifen
NZ542499A (en) 2003-04-01 2008-10-31 Besins Int Lab Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
ATE472102T1 (de) * 2003-12-26 2010-07-15 Takeda Pharmaceutical Verfahren zur vorhersage von anomalien des lipidmetabolismus
MY145634A (en) * 2003-12-29 2012-03-15 Bristol Myers Squibb Co Pyrrolotriazine compounds as kinase inhibitors
US20060105045A1 (en) * 2004-11-08 2006-05-18 Buchanan Charles M Cyclodextrin solubilizers for liquid and semi-solid formulations
US20090291134A1 (en) * 2006-11-21 2009-11-26 Jina Pharmaceuticals, Inc. Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases
US8017403B2 (en) * 2007-06-14 2011-09-13 Quest Diagnostics Investments Incorporated Mass spectrometry method for measuring vitamin B6 in body fluid
US20090134325A1 (en) * 2007-11-27 2009-05-28 Goldman Mildred M Methods for detecting estradiol by mass spectrometry
US8916385B2 (en) * 2007-12-13 2014-12-23 Quest Diagnostics Investments, Inc. Methods for detecting estrone by mass spectrometry
US7834313B2 (en) 2008-08-08 2010-11-16 Quest Diagnostics Investments Incorporated Mass spectrometry assay for plasma-renin
JP2012517238A (ja) * 2009-02-11 2012-08-02 カリス エムピーアイ インコーポレイテッド 腫瘍の分子プロファイリング法
JP5953232B2 (ja) * 2009-10-06 2016-07-20 ウィスコンシン・アルムニ・リサーチ・ファウンデーションＷｉｓｃｏｎｓｉｎ Ａｌｕｍｎｉ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 薬物誘導性の心毒性の代謝バイオマーカー
WO2012119010A2 (en) * 2011-03-01 2012-09-07 Indiana University Research And Technology Corporation Materials for inhibiting aromatase and method of using the same to diagnose, treat and monitor breast cancer
WO2012167126A1 (en) * 2011-06-03 2012-12-06 Purdue Research Foundation Ion generation using modified wetted porous materials
CN104203961B (zh) * 2012-03-05 2017-05-17 泽维尔大学 作为用于治疗乳腺癌的基于硼的4‑羟基他莫昔芬和因多昔芬前药
WO2014014279A1 (ko) * 2012-07-17 2014-01-23 서울대학교 산학협력단 질량 스펙트럼의 재현성 향상 방법 및 이를 이용한 정량 분석 방법
CN103494787B (zh) * 2013-07-22 2014-10-29 南通广泰生化制品有限公司 枸橼酸他莫昔芬滴丸
AU2015259294A1 (en) * 2014-05-12 2016-12-01 Quest Diagnostics Investments Llc Quantitation of tamoxifen and metabolites thereof by mass spectrometry

Similar Documents

Publication Publication Date Title
JP2018077253A5 (enExample)
JP2017516104A5 (enExample)
Helm et al. Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomics
Van Belkum et al. Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories
JP2011504596A5 (enExample)
JP2011505013A5 (enExample)
JP2011530701A5 (enExample)
BR112017025097A2 (pt) método para quantificação espectrométrica de massa de analitos extraídos de um dispositivo de microamostragem
EP3570315A3 (en) Rapid evaporative ionisation mass spectrometry ("reims") and desorption electrospray ionisation mass spectrometry ("desi-ms") analysis of biopsy samples
WO2006130474A3 (en) Multi-beam ion mobility time-of-flight mass spectrometer with bipolar ion extraction and zwitterion detection
Pegalajar-Jurado et al. Identification of urine metabolites as biomarkers of early Lyme disease
WO2015184321A3 (en) Rare molecule detection
Chingin et al. Rapid recognition of bacteremia in humans using atmospheric pressure chemical ionization mass spectrometry of volatiles emitted by blood cultures
SA516380291B1 (ar) الحساب الكمي لتاموكسيفين ونواتج أيضه بواسطة القياس الطيفي الكتلي
Pinto et al. Identification of SARS-CoV-2 proteins from nasopharyngeal swabs probed by multiple reaction monitoring tandem mass spectrometry
Meisen et al. Direct coupling of high-performance thin-layer chromatography with UV spectroscopy and IR-MALDI orthogonal TOF MS for the analysis of cyanobacterial toxins
Liu et al. Matrix effects in the liquid chromatography-tandem mass spectrometry method of analysis
Reddy et al. Development and validation of a rapid ultra high performance liquid chromatography with tandem mass spectrometry method for the simultaneous determination of darunavir, ritonavir, and tenofovir in human plasma: Application to human pharmacokinetics
Kailasa et al. Electrospray ionization tandem mass spectrometry for rapid, sensitive and direct detection of melamine in dairy products
RU2018104707A (ru) ИСПОЛЬЗОВАНИЕ МОЛЕКУЛЯРНЫХ МАРКЕРОВ IL-3, IL-33 и IL12ρ40 ДЛЯ ХАРАКТЕРИСТИКИ СТЕПЕНИ ТЯЖЕСТИ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ, ВЫЗВАННЫХ РЕСПИРАТОРНО-СИНЦИТИАЛЬНЫМ ВИРУСОМ ЧЕЛОВЕКА И МЕТАПНЕВМОВИРУСОМ ЧЕЛОВЕКА
Ishii et al. Simple and sensitive determination of α-and β-amanitin by liquid chromatography–quadrupole time-of-flight mass spectrometry
Rincón et al. Evaluation of peripheral blood microsampling techniques in combination with liquid chromatography‐high resolution mass spectrometry for the determination of drug pharmacokinetics in clinical studies
Schreiber et al. LC-MS/MS analysis of emerging food contaminants
Kalló et al. Relative quantification of human β‐defensins by a proteomics approach based on selected reaction monitoring
CN206059342U (zh) 一种双极性质子转移反应质谱的有机物检测装置